当前位置: X-MOL 学术J. Crohns Colitis › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Leukocytoclastic Vasculitis Related to Ustekinumab in a Crohn's Disease Patient: First Case Report and Literature Review.
Journal of Crohn's and Colitis ( IF 8.3 ) Pub Date : 2020-02-10 , DOI: 10.1093/ecco-jcc/jjz128
Pedro Costa-Moreira 1, 2 , Susana Lopes 1, 3 , Ana Luísa Santos 1, 2 , Ana Filipa Pedrosa 4 , Patrícia Andrade 1, 2 , Raquel Portugal 2, 3 , Guilherme Macedo 1, 2
Affiliation  

Leukocytoclastic vasculitis is a single-organ, skin-isolated small vessel vasculitis. It can be a side effect of many common drugs, including biological agents. Unlike with other drugs, leukocytoclastic vasculitis induced by biological agents may have a prolonged latency period. We report the first case of ustekinumab-induced leukocytoclastic vasculitis in a patient with inflammatory bowel disease.

中文翻译:

克罗恩病患者中与乌斯他单抗有关的白细胞破管性血管炎:第一例病例报告和文献复习。

白细胞碎裂性血管炎是一种单器官,皮肤隔离的小血管性血管炎。它可能是许多常见药物(包括生物制剂)的副作用。与其他药物不同,由生物制剂诱导的白细胞碎裂性血管炎可能会延长潜伏期。我们在炎症性肠病患者中报告了ustekinumab诱导的白细胞碎裂性血管炎的第一例。
更新日期:2020-02-10
down
wechat
bug